Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484717 · ClinicalTrials.gov registry record · Phase 2
Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation
A Phase 2 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT01484717 is a Phase 2 study that has completed, run by UConn Health. The registered enrollment target is 90 participants.
The verdict
NCT01484717, a Phase 2 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
Cigarette smoking remains the most common source of preventable morbidity and mortality in the United States, with in excess of $167 billion in economic costs per year. Contingency management (CM), in which tangible incentives are provided contingent on a target behavior like abstinence, is highly efficacious in improving substance abuse treatment outcomes and is receiving increased attention for smoking cessation. Expired carbon monoxide (CO) is the most common objective smoking status test used in smoking research and treatment. Unfortunately, multiple CO tests/day are typically required to detect all smoking and reinforce sustained abstinence. The resulting logistical and resource limitations greatly limit the application of this potentially powerful quit smoking toolset. This study addresses these limitations by examining the effectiveness of using interactive voice response technology (IVR) to implement CM. Smokers who want to quit (N = 90 randomized) will receive 2 quit preparation sessions based on public health guidelines for smoking cessation and set a target quit date. Participants will be randomly assigned to 1 of 2 treatment conditions: (a) IVR-S consisting of objective smoking status monitoring using IVR, telephone counseling and transdermal nicotine and (b) IVR-CM, consisting of the same monitoring, telephone counseling and transdermal nicotine plus IVR-based CM for smoking abstinence. It is hypothesized that abstinence rates will be higher in the IVR-CM condition compared to the IVR-S, supporting a combined IVR CM approach, and thereby greatly increasing the applicability of these powerful smoking cessation tools.
Interventions
- BEHAVIORAL Telephone counseling
- BEHAVIORAL contingency management for smoking abstinence
- DRUG transdermal nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01484717
The ClinicalTrials.gov registry entry for NCT01484717 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Telephone counseling is the first listed.
NCT01484717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01484717 about?
NCT01484717 is a clinical study titled "Interactive Voice Response Technology to Mobilize Contingency Management for Smoking Cessation". Cigarette smoking remains the most common source of preventable morbidity and mortality in the United States, with in excess of $167 billion in economic costs per year. Contingency management (CM), in which tangible incentives are provided contingent on a target behavior like abstinence, is highly e...
What is the current status of trial NCT01484717?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2012-01. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01484717?
The interventions under investigation include: Telephone counseling (BEHAVIORAL), contingency management for smoking abstinence (BEHAVIORAL), transdermal nicotine (DRUG).
Who is sponsoring clinical trial NCT01484717?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.